Clinical Trial Update: Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating adavosertib in combination with radiation therapy and temozolomide for newly diagnosed or recurrent glioblastoma; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Adavosertib (adavosertib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Glioblastoma, Recurrent Glioblastoma | Phase 1 | Status: COMPLETED